Search Results 551-560 of 15886 for SC
The research of Dr. Hayashi's lab will determine the molecular and epigenetic mechanisms that drive ICC-SC decline, a putative mechanism of ICC loss and age- ...
Eastlack SC, et al. Kratom — Pharmacology, clinical implications, and outlook: A comprehensive review. · Sevarino KA. Medically supervised opioid withdrawal ...
... SC, Lin Y. Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease ...
... (SC) inclisiran injection(s). The study will be a multicenter study in the United States. Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and ...
We recognize older adults with SC are heterogeneous and have been variably defined, however, our definition conforms to the international Subjective ...
... SC, Gamez M, Holtzmann A, Mohammadi H, Garcia J, Chintakuntlawar A, Price KA, Fuentes Bayne HE, Rwigema JCM, Patel SH, McGee LA, Patel S, Janus JR, Chang B ...
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC ... [SC]), and an immunomodulator (oral methotrexate) on endoscopic remission in ...
Rozen-Zvi B, Hayashida T, Hubchak SC, Hanna C, Platanias LC, Schnaper HW. TGF-beta/Smad3 activates mammalian target of rapamycin complex-1 to promote ...
Lalla SC, Kumar AB, Lehman JS, Lohse CM, Brewer JD. Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A ...
B.A.Sc. - ChemistrySt. Olaf College. Show more education. Activities and honors. Certifications. 2003. Pediatric GastroenterologyAmerican Board of Pediatrics ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.